Prolonged responses after autologous stem cell transplantation in African-American patients with multiple myeloma
Authors:
- 8 May 2006
- journal article
- research article
- Published by Springer Nature in Bone Marrow Transplantation
- Vol. 37 (12) , 1099-1102
Abstract
Multiple myeloma (MM) has a double incidence in African-American (AA) than in non-AA patients and previous studies have shown a higher mortality in the former patient population. Here, we retrospectively analyzed the results of autologous stem cell transplantation (ASCT) in 38 AA and 32 non-AA consecutive patients. The two groups were comparable at diagnosis for age, stage of the disease, cytogenetic abnormalities, β2 microglobulin and albumin blood levels, and plasma cell marrow infiltration. The rates of complete and partial response observed in AA and non-AA patients after induction chemotherapy (9 and 42 vs 13 and 33%) and at 2 months (31 and 25 vs 30 and 20%) following ASCT were similar. At 6 months after ASCT, a greater relapse rate was observed in non-AA patients (P=0.009). At a median follow-up of 26 months, AA patients had a greater event-free survival (P=0.02) than non-AA patients, whereas overall survival was comparable in the two groups. The initial finding that AA patients with MM, compared to non-AA patients, had more prolonged responses and comparable survival after ASCT suggests that intensified chemotherapy is equally effective in patients of various ethnicities.Keywords
This publication has 17 references indexed in Scilit:
- Effects of race on survival after stem cell transplantationTransplantation and Cellular Therapy, 2005
- Myeloma and race: A review of the literatureCancer and Metastasis Reviews, 2003
- Diet and nutrition as risk factors for multiple myeloma among blacks and whites in the United StatesCancer Causes & Control, 2001
- Socioeconomic status and multiple myeloma among US blacks and whitesAmerican Journal of Public Health, 2000
- Multiple myeloma and family history of cancer among blacks and whites in the U.S.Cancer, 1999
- CRITERIA FOR EVALUATING DISEASE RESPONSE AND PROGRESSION IN PATIENTS WITH MULTIPLE MYELOMA TREATED BY HIGH‐DOSE THERAPY AND HAEMOPOIETIC STEM CELL TRANSPLANTATIONBritish Journal of Haematology, 1998
- Multiple myeloma among Blacks and Whites in the United States: role of cigarettes and alcoholic beveragesCancer Causes & Control, 1997
- A Prospective, Randomized Trial of Autologous Bone Marrow Transplantation and Chemotherapy in Multiple MyelomaNew England Journal of Medicine, 1996
- Socioeconomic Status and the Incidence of Multiple MyelomaEpidemiology, 1996
- Multiple myeloma among blacks and Whites in the United States: the role of chronic antigenic stimulationCancer Causes & Control, 1994